Kenya’s healthcare sector is one of the fastest-growing in all of Africa, however, almost all of the country’s medical devices are imported.  As Kenya continues to meet increasing demand for modern healthcare solutions, the growth in the market is offering new partnership opportunities for U.S. companies in a dynamic African market.

While the Kenyan government planned new investments to upgrade intensive care units, dialysis centers, chemotherapy facilities and cancer diagnostic centers, USTDA organized a timely reverse trade mission to engage with trusted Kenyan partners and connect American companies with these new opportunities. The visit significantly helped Kenya modernize its healthcare delivery for non-communicable diseases.

The trade mission brought together delegates from the Kenyan Ministry of Health and public and private healthcare institutions with leading medical technology and service providers from the United States. As a result, the Kenyan delegates procured diagnostic and radiology equipment to treat cancer and mobile x-rays to combat tuberculosis. To maximize Kenya’s investment in quality infrastructure, U.S. vendors also supplied services to install the equipment, train users and provide maintenance.

These purchases have measurably enhanced patient access for Kenya’s citizens, including better equipment, innovative treatment therapies and new information technology systems. Thanks to this improved infrastructure, Kenya hospitals have also improved efficiency and accuracy, while also reducing costs.

USTDA Acting Director Thomas Hardy concludes that these initiatives are a signature achievement: “Our Agency is positioning U.S. companies at the forefront of medical innovation and patient care, helping to transform the healthcare landscape for our Kenyan partners.”

July 14, 2020